Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1989 Dec;78(3):359–365.

Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis.

C M Holt 1, N Lindsey 1, J Moult 1, R G Malia 1, M Greaves 1, A Hume 1, N R Rowell 1, P Hughes 1
PMCID: PMC1534812  PMID: 2612050

Abstract

Ten sera from 48 patients with systemic sclerosis were found to be capable of producing cytotoxicity of human umbilical venous and arterial endothelium when co-cultured with peripheral blood mononuclear cells. Fractionation of sera on Ultrogel and the preparation of monomeric IgG by ion exchange and affinity chromatography suggested that the cytotoxicity was mediated by anti-endothelial antibodies capable of pre-sensitizing target cells in a mechanism that resembled antibody-dependent cellular cytotoxicity. These anti-endothelial antibodies together with C1q-binding immune complexes and anti-cardiolipin antibodies were found in 18 of 28 patients so investigated, suggesting that multiple immunological mechanisms may be involved in the pathogenesis of the vascular lesion of systemic sclerosis.

Full text

PDF
363

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alcocer-Varela J., Martinez-Cordero E., Alarcon-Segovia D. Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma. Clin Exp Immunol. 1985 Mar;59(3):666–672. [PMC free article] [PubMed] [Google Scholar]
  2. Aronson F. R., Libby P., Brandon E. P., Janicka M. W., Mier J. W. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury. J Immunol. 1988 Jul 1;141(1):158–163. [PubMed] [Google Scholar]
  3. Bernstein R. M., Steigerwald J. C., Tan E. M. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol. 1982 Apr;48(1):43–51. [PMC free article] [PubMed] [Google Scholar]
  4. Greaves M., Malia R. G., Milford Ward A., Moult J., Holt C. M., Lindsey N., Hughes P., Goodfield M., Rowell N. R. Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease. Br J Rheumatol. 1988 Aug;27(4):281–285. doi: 10.1093/rheumatology/27.4.281. [DOI] [PubMed] [Google Scholar]
  5. Greenberg A. H., Shen L. A class of specific cytotoxic cells demonstrated in vitro by arming with antigen-antibody complexes. Nat New Biol. 1973 Oct 31;245(148):282–285. doi: 10.1038/newbio245282a0. [DOI] [PubMed] [Google Scholar]
  6. Hashemi S., Smith C. D., Izaguirre C. A. Anti-endothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay. J Lab Clin Med. 1987 Apr;109(4):434–440. [PubMed] [Google Scholar]
  7. Hughes P., Cunningham J., Day M., Fitzgerald J. C., French M. A., Wright J. K., Rowell N. R. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays. J Clin Lab Immunol. 1983 Mar;10(3):133–138. [PubMed] [Google Scholar]
  8. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Malia R. G., Greaves M., Rowlands L. M., Lawrence A. C., Hume A., Rowell N. R., Moult J., Holt C. M., Lindsey N., Hughes P. Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations. Clin Exp Immunol. 1988 Sep;73(3):456–460. [PMC free article] [PubMed] [Google Scholar]
  10. Maricq H. R., LeRoy E. C., D'Angelo W. A., Medsger T. A., Jr, Rodnan G. P., Sharp G. C., Wolfe J. F. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 1980 Feb;23(2):183–189. doi: 10.1002/art.1780230208. [DOI] [PubMed] [Google Scholar]
  11. Marks R. M., Czerniecki M., Andrews B. S., Penny R. The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity. Arthritis Rheum. 1988 Dec;31(12):1524–1534. doi: 10.1002/art.1780311209. [DOI] [PubMed] [Google Scholar]
  12. Marks R. M., Czerniecki M., Penny R. Killing of human dermal capillary endothelial cells by antibody-dependent cellular cytotoxicity. J Invest Dermatol. 1986 Oct;87(4):519–523. doi: 10.1111/1523-1747.ep12455604. [DOI] [PubMed] [Google Scholar]
  13. Norton W. L., Nardo J. M. Vascular disease in progressive systemic sclerosis (scleroderma). Ann Intern Med. 1970 Aug;73(2):317–324. doi: 10.7326/0003-4819-73-2-317. [DOI] [PubMed] [Google Scholar]
  14. Penning C. A., Cunningham J., French M. A., Harrison G., Rowell N. R., Hughes P. Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis. Clin Exp Immunol. 1984 Sep;57(3):548–556. [PMC free article] [PubMed] [Google Scholar]
  15. Penning C. A., Wright J. K., Ashby J. C., Cunningham J., Rowell N. R., Hughes P. Serum-induced enhancement of peripheral blood mononuclear cell-mediated cytotoxicity towards human target cells in systemic sclerosis. J Clin Lab Immunol. 1983 Oct;12(2):77–81. [PubMed] [Google Scholar]
  16. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980 May;23(5):581–590. doi: 10.1002/art.1780230510. [DOI] [PubMed] [Google Scholar]
  17. Rosenbaum J., Pottinger B. E., Woo P., Black C. M., Loizou S., Byron M. A., Pearson J. D. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol. 1988 Jun;72(3):450–456. [PMC free article] [PubMed] [Google Scholar]
  18. Short P. E., Williams C. E., Picken A. M., Hill F. G. Factor VIII related antigen: an improved enzyme immunoassay. Med Lab Sci. 1982 Oct;39(4):351–355. [PubMed] [Google Scholar]
  19. TUFFANELLI D. L. Scleroderma and its relationship to the "collagenoses": dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome. Am J Med Sci. 1962 Feb;243:133–146. [PubMed] [Google Scholar]
  20. Vismara A., Meroni P. L., Tincani A., Harris E. N., Barcellini W., Brucato A., Khamashta M., Hughes G. R., Zanussi C., Balestrieri G. Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol. 1988 Nov;74(2):247–253. [PMC free article] [PubMed] [Google Scholar]
  21. van der Maulen J., Wouda A. A., Mandema E., The T. H. Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon. Clin Exp Immunol. 1979 Jan;35(1):62–66. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES